Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arata Azuma

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Respiratory Investigation|December 28, 2014
Searching hidden truth behind clinical trialsArata Azuma
Respiratory Investigation|December 26, 2016
Safety management of treatment with nintedanib in clinical practice of IPFArata Azuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Fibrosis of the viscera and its treatment; 3). Pulmonary fibrosis and its management]Arata Azuma
Expert Review of Respiratory Medicine|June 8, 2010
Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosisArata Azuma
Internal Medicine (Tokyo, Japan)|July 16, 2005
Shared mechanisms of lung injury and subsequent fibrosis: role of surfactant proteins in the pathogenesis of interstitial pneumonia in Hermansky-Pudlak SyndromeArata Azuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 17, 2005
[Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions]Arata Azuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 19, 2006
[Newly developed therapeutic drugs for idiopathic interstitial pneumonias]Arata Azuma
Therapeutic Advances in Respiratory Disease|February 16, 2012
Pirfenidone treatment of idiopathic pulmonary fibrosisArata Azuma
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 1, 2005
[Expectation of new treatments for idiopathic interstitial pneumonias]Arata Azuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Idiopathic pulmonary fibrosis (IPF)]Aki Matsumoto, Arata Azuma
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Respiratory Investigation|December 28, 2014
Searching hidden truth behind clinical trialsArata Azuma
Respiratory Investigation|December 26, 2016
Safety management of treatment with nintedanib in clinical practice of IPFArata Azuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Fibrosis of the viscera and its treatment; 3). Pulmonary fibrosis and its management]Arata Azuma
Expert Review of Respiratory Medicine|June 8, 2010
Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosisArata Azuma
Internal Medicine (Tokyo, Japan)|July 16, 2005
Shared mechanisms of lung injury and subsequent fibrosis: role of surfactant proteins in the pathogenesis of interstitial pneumonia in Hermansky-Pudlak SyndromeArata Azuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 17, 2005
[Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions]Arata Azuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 19, 2006
[Newly developed therapeutic drugs for idiopathic interstitial pneumonias]Arata Azuma
Therapeutic Advances in Respiratory Disease|February 16, 2012
Pirfenidone treatment of idiopathic pulmonary fibrosisArata Azuma
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 1, 2005
[Expectation of new treatments for idiopathic interstitial pneumonias]Arata Azuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Idiopathic pulmonary fibrosis (IPF)]Aki Matsumoto, Arata Azuma
Pageof 23